It is is aimed at all EudraVigilance users who have to report and analyse suspected adverse reactions in the pre- and post-authorisation phase. This includes:
Using the ISO ICSR/ICH E2B(R3) format and related terminologies became mandatory on 30 June 2022. For more information, refer to Guidance on using new ISO standard format for individual case safety reports under Change management for the EudraVigilance system.
4 Dec 2023 @ 08:00 am
8 Dec 2023 @ 12:30 pm
Duration: 4 days, 4 hours
Timezone: GMT +2:00
Online Webinar
Englishen